OSCAR FEINSILVER, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
To the Editor: I read with considerable interest the editorial "Isoproterenol for the Treatment of Shock" (Ann. Intern. Med. 70: 638, 1969). It is clear that the author feels that isoproterenol is indicated when the balance that exists between the beneficial effects of the drug on the circulation and delivery of oxygen exceeds the harmful effects. The latter, it was shown, consists of the production of myocardial ischemia by stimulation of the heart beyond the available oxygen supply. Another consideration that might interfere with the usefulness of isoproterenol is the shunting through the lung produced by the drug with consequent
FEINSILVER O. ISOPROTERENOL FOR SHOCK. Ann Intern Med. 1969;71:867. doi: https://doi.org/10.7326/0003-4819-71-4-867_1
Download citation file:
Published: Ann Intern Med. 1969;71(4):867.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use